$CCXI News

Churchill Capital Corp XI: First To Market Humanoid Robotics

Why CCXI Stock Is Climbing Wednesday Following Unitree's Blockbuster IPO

Churchill Capital Stock Rises as Sponsor Financing Adds Fuel to Agility Robotics Merger Plans

FTC Grants Antitrust Clearance For Business Combination Between Churchill Capital And Agility Robotics

Churchill Capital Shares Rise as $2.5 Billion Agility Robotics Merger Keeps Investors Engaged

Churchill Capital Stock Is Surging Wednesday: What Investors Need to Know

Churchill Capital Stock Edges Lower Tuesday: What The Latest SEC Filings Reveal

Churchill Capital Stock Surges On $2.5B Merger With Agility Robotics: What Investors Need To Know

Agility Robotics goes public with Churchill Capital SPAC merger

Churchill Capital Corp XI Surges After Announcing Agility Robotics Merger (CCXI)

Churchill Capital Corp XI And Agility Robotics To Merge In $2.5B SPAC Transaction; Agility To Trade Under Symbol 'AGLT'

Agility Robotics to go public in $2.5 billion deal with Michael Klein-backed SPAC

Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026

ChemoCentryx shares are trading higher after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.

ChemoCentryx Upgraded To Strong Buy At Raymond James, Raises Price Target From $62 To $107; Says Regulatory Risk Is Removed, Says Thinks Tavneos Approval Will Be Blockbuster

ChemoCentryx Shares Tick Higher On Volume As Traders Circulate Upgrade To Strong Buy From Analyst At Raymond James

Why ChemoCentryx (CCXI) Stock Might be a Great Pick

ChemoCentryx, Inc. Just Reported Full-Year Earnings And Analysts Are Lifting Their Estimates

Edited Transcript of CCXI earnings conference call or presentation 10-Mar-20 9:00pm GMT

ChemoCentryx (CCXI) Reports Q4 Loss, Tops Revenue Estimates